Expression of RECK and MMPS in hepatoblastoma and neuroblastoma and comparative analysis on the tumor metastasis

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 9, 2015, Pages 4007-4011

  Xu, Meng ^a   Wang, Hai Feng ^a   Zhang, Huan Zhi ^b  

^a Yishui Central Hospital   (China)

^b Anqiu People's Hospital   (China)

Author keywords

Hepatoblastoma; Matrix metalloproteinase; Metastasis; Neuroblastoma; RECK

Indexed keywords

GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MATRIX METALLOPROTEINASE 14; MMP14 PROTEIN, HUMAN; RECK PROTEIN, HUMAN; TUMOR MARKER;

CANCER STAGING; CHILD; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HEPATOBLASTOMA; HUMAN; INFANT; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; NEUROBLASTOMA; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; SECONDARY;

BIOMARKERS, TUMOR; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GPI-LINKED PROTEINS; HEPATOBLASTOMA; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 14; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS;

EID: 84930159041     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.9.4007     Document Type: Article

References (17)

1. Alexius-Lindgren M, Andersson E, Lindstedt I, et al (2014). The RECK gene and biological malignancy--its significance in angiogenesis and inhibition of matrix metalloproteinases. Anticancer Res, 34, 3867-73.
2. Cho YB, Lee WY, Song SY, et al (2007). Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer. Hum Pathol, 38, 1603-10.
3. Clark JC, Thomas DM, Choong PF, et al (2007). RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev, 26, 675-83.
4. Furumoto K, Arii S, Mori A, et al (2001). RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs. Hepatology, 33, 189-95.
5. Jeon HW, Lee YM (2010). Inhibition of histone deacetylase attenuates hypoxia-induced migration andinvasion of cancer cells via the restoration of RECK expression. Mol Cancer Ther, 9, 1361-70.
6. Khaderi S, Guiteau J, Cotton RT, et al (2014). Role of liver transplantation in the management of hepatoblastoma in the pediatric population. World J Transplant, 4, 294-8.
7. Kimura T, Okada A, Yatabe T, et al (2010). RECK is up-regulated and involved in chondrocyte cloning in humanosteoarthritic cartilage. Am J Pathol, 176, 2858-67.
8. Kremer N, Walther AE, Tiao GM (2014). Management of hepatoblastoma: an update. Curr Opin Pediatr, 26, 362-9.
9. Martínez-Criado Y, Cabello R, Fernández-Pineda I, et al (2013). Study of the expression of neural stem cell markers in neuroblastoma tumor samples and correlation with prognostic factors. Cir Pediatr, 26, 112-8.
10. Morandi F, Corrias MV, Pistoia V (2015). Evaluation of bone marrow as a metastatic site of human neuroblastoma. Ann N Y Acad Sci, 1335, 23-31.
11. Peters H, Augusto TM, Bruni-Cardoso A, et al (2010). RECK expression in the rat ventral prostate: response to castration involves a balance between epithelial and stromal expression. Anat Rec (Hoboken), 293, 993-7.
12. Verma S, Kesh K, Ganguly N, et al (2014). Matrix metalloproteinases and gastrointestinal cancers: Impacts of dietary antioxidants. World J Biol Chem, 5, 355-76.
13. Wang JL, Wu DW, Cheng ZZ, et al (2014). Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC). Asian Pac J Cancer Prev, 15, 4865-9.
14. Xie J, Tan ZH, Tang X, et al (2014). MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis. World J Gastroenterol, 20, 17439-47.
15. Yáñez Y, Grau E, Rodríguez-Cortez VC, et al (2015). Two independent epigenetic biomarkers predict survival in neuroblastoma. Clin Epigenetics, 7, 16.
16. Yang L, Li N, Wang S, et al (2014). Lack of association between the matrix metalloproteinase-2 -1306C>T polymorphism and breast cancer susceptibility: a meta-analysis. Asian Pac J Cancer Prev, 15, 4823-7.
17. Zhang Y, Zhang WL, Huang DS, et al (2013). Clinical efficacy and prognosis factors for advanced hepatoblastoma in children: a 6-year retrospective study. Asian Pac J Cancer Prev, 14, 4583-9.